» Articles » PMID: 25820430

Distribution of DNA-condensing Protein Complexes in the Adenovirus Core

Overview
Specialty Biochemistry
Date 2015 Mar 31
PMID 25820430
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Genome packing in adenovirus has long evaded precise description, since the viral dsDNA molecule condensed by proteins (core) lacks icosahedral order characteristic of the virus protein coating (capsid). We show that useful insights regarding the organization of the core can be inferred from the analysis of spatial distributions of the DNA and condensing protein units (adenosomes). These were obtained from the inspection of cryo-electron tomography reconstructions of individual human adenovirus particles. Our analysis shows that the core lacks symmetry and strict order, yet the adenosome distribution is not entirely random. The features of the distribution can be explained by modeling the condensing proteins and the part of the genome in each adenosome as very soft spheres, interacting repulsively with each other and with the capsid, producing a minimum outward pressure of ∼0.06 atm. Although the condensing proteins are connected by DNA in disrupted virion cores, in our models a backbone of DNA linking the adenosomes is not required to explain the experimental results in the confined state. In conclusion, the interior of an adenovirus infectious particle is a strongly confined and dense phase of soft particles (adenosomes) without a strictly defined DNA backbone.

Citing Articles

Role of Protein VII in the Production of Infectious Bovine Adenovirus-3 Virion.

Kulanayake S, Singh B, Dar F, Tikoo S Viruses. 2024; 16(8).

PMID: 39205297 PMC: 11359501. DOI: 10.3390/v16081323.


Regions of Bovine Adenovirus-3 Protein VII Involved in Interactions with Viral and Cellular Proteins.

Kulanayake S, Dar F, Tikoo S Viruses. 2024; 16(5).

PMID: 38793614 PMC: 11125828. DOI: 10.3390/v16050732.


Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.

Scarsella L, Ehrke-Schulz E, Paulussen M, Thal S, Ehrhardt A, Aydin M Viruses. 2024; 16(3).

PMID: 38543743 PMC: 10974029. DOI: 10.3390/v16030377.


Delivery of gene editing therapeutics.

Kevadiya B, Islam F, Deol P, Zaman L, Mosselhy D, Ashaduzzaman M Nanomedicine. 2023; 54:102711.

PMID: 37813236 PMC: 10843524. DOI: 10.1016/j.nano.2023.102711.


Adenovirus entry: Stability, uncoating, and nuclear import.

Greber U, Suomalainen M Mol Microbiol. 2022; 118(4):309-320.

PMID: 35434852 PMC: 9790413. DOI: 10.1111/mmi.14909.


References
1.
Chatterjee P, Yang U, Flint S . Comparison of the interactions of the adenovirus type 2 major core protein and its precursor with DNA. Nucleic Acids Res. 1986; 14(6):2721-35. PMC: 339694. DOI: 10.1093/nar/14.6.2721. View

2.
Mirza M, Weber J . Structure of adenovirus chromatin. Biochim Biophys Acta. 1982; 696(1):76-86. DOI: 10.1016/0167-4781(82)90012-4. View

3.
Saper G, Kler S, Asor R, Oppenheim A, Raviv U, Harries D . Effect of capsid confinement on the chromatin organization of the SV40 minichromosome. Nucleic Acids Res. 2012; 41(3):1569-80. PMC: 3561987. DOI: 10.1093/nar/gks1270. View

4.
Cuervo A, Dauden M, Carrascosa J . Nucleic acid packaging in viruses. Subcell Biochem. 2013; 68:361-94. DOI: 10.1007/978-94-007-6552-8_12. View

5.
Puntener D, Engelke M, Ruzsics Z, Strunze S, Wilhelm C, Greber U . Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol. 2010; 85(1):481-96. PMC: 3014209. DOI: 10.1128/JVI.01571-10. View